Search Results 21-30 of 11340 for ������������KA���:ZA31���24������ ���������������������������������

  1. Dabigatran (Oral Route) Side Effects - Mayo Clinic

    Children 18 to less than 24 months of age weighing 21 to less than 26 kilograms (kg)—180 milligrams (mg) 2 times a day (one 30 mg packet plus one 150 mg packet ...

  2. 'I wouldn't be here:' Jacki Crane credits valve procedure with saving her life  - Mayo Clinic News Network

    Tests showed I had 24% lung function, and around Labor Day 2018, I had a heart attack. How Mayo Clinic came into my life. After improving somewhat from my ...

  3. Mayo Clinic Comprehensive Cancer Center — Research

    The purpose of this study is to estimate the impact of a 6‐week daily intake of 2000 mg of ginger extract on the composition of the gut microbiome using a ...

  4. centers-of-excellence

    Holter monitor Holter monitor A Holter monitor uses electrodes and a recording device to track the heart's rhythm for 24 to 72 hours.

  5. Publications - Katie A. Young, M.D. - Mayo Clinic

    Lyle M, Miranda WR, Vaidya VR, Rose CH, Melduni RM, Connolly HM, Young KA. Pregnancy Outcomes in Left Ventricular Noncompaction. Am J Cardiol. 2023 Dec 15; 209: ...

  6. Mayo Clinic Comprehensive Cancer Center — Research

    The study is designed to determine if guselkumab has clinical activity in the colorectum and duodenum, by reducing the number of polyps over a period of 24 ...

  7. Use of Midodrine in Septic Shock Patients - Mayo Clinic

    Study IDs · Rochester, Minnesota: 24-000121 · Mankato, Minnesota: 24-000121 · Jacksonville, Florida: 24-000121 · Eau Claire, Wisconsin: 24-000121 · Scottsdale/ ...

  8. Menopause - Diagnosis and treatment - Mayo Clinic

    Martin KA, et al. Treatment of menopausal symptoms with hormone therapy. https://www.uptodate.com/contents/search. Accessed April 2, 2024. Menopause. U.S. ...

  9. Mayo Clinic Comprehensive Cancer Center — Research

    The purpose of this study of sulfasalazine is to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic ...

  10. A Multicenter Open Label Trial Using Ambrisentan in Patients with Porto-pulmonary Hypertension - Mayo Clinic

    In addition, the Investigator will assess each subject for safety and efficacy at Week 4, Week 12, and Week 24. Following Week 24, subjects will be assessed for ...